Related Experiment Video
Updated: Jun 17, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
Cardiac troponin may be released by ischemia alone, without necrosis
Peter E Hickman1, Julia M Potter, Con Aroney
1Australian National University Medical School, Canberra, ACT 2605, Australia. peter.hickman@anu.edu.au
Insights
Cardiac troponin can be released into the circulation without heart cell death (necrosis). This occurs via membranous blebs forming during ischemia, offering a new understanding of troponin release in cardiac conditions.
Area of Science:
- Cardiology
- Cell Biology
- Biochemistry
Background:
- Cardiac troponin is typically associated with myocardial necrosis.
- Elevated troponin levels are observed in clinical scenarios without apparent cardiac injury.
- Troponin half-life is shorter in non-necrotic release events.
Purpose of the Study:
- To investigate the mechanism of troponin release in the absence of myocyte necrosis.
- To explore the role of cellular blebbing in cardiac troponin release.
- To provide evidence supporting troponin release solely due to ischemia.
Main Methods:
- Review of existing cardiac studies.
- Analysis of cellular mechanisms for macromolecule release.
- Investigation of membranous bleb formation in cardiac myocytes.
Main Results:
- A mechanism involving membranous blebs allows cytoplasmic contents, including troponin, to exit cells without necrosis.
- Blebs form during ischemia and can be released into circulation upon re-oxygenation.
- Evidence supports the presence of these blebs in cardiac myocytes.
Conclusions:
- Cardiac troponin can be released from myocytes due to ischemia alone, independent of necrosis.
- Membranous blebbing provides a mechanism for non-necrotic troponin release.
- This finding has implications for understanding troponin kinetics in various clinical conditions.
Abstract:
Whilst it is formally stated that cardiac troponin is only released when cardiac myocytes undergo necrosis, there are a number of clinical situations where troponin is present in the circulation, without any apparent cardiac injury. In these cases, troponin half-life in the circulation is usually substantially shorter than that seen when troponin is released following myocardial infarction with frank necrosis. A mechanism has been described in liver, where large cytoplasmic molecules can pass from the intra- to extra-cellular space without cellular necrosis occurring. This occurs by the formation of membranous blebs which bud off from the plasma membrane of the cell. Blebs develop during cellular ischemia. If the ischemia is limited and re-oxygenation occurs, the blebs may be released into the circulation without rupture of the plasma membrane, resulting in a one-off release of cytoplasmic contents including macromolecules. Evidence from cardiac studies is presented supporting the presence of membranous blebs in cardiac myocytes, enabling troponin to be released from cardiac cells due to ischemia alone, without necrosis.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cellular Injury IV: Necrosis
Myocarditis I: Introduction
